文献速递乳房整形与再造显微修复重建

新辅助治疗后即刻DIEP皮瓣乳房重建:内乳动脉与腹壁下深动脉血管完整性的组织病理学评估

Immediate DIEP flap breast reconstruction following neoadjuvant therapy: Histopathological assessment of vascular integrity in internal mammary and deep inferior epigastric arteries.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-08-26

该单中心回顾性队列纳入2019至2023年83例乳腺癌行保留乳头乳晕乳房切除并即刻DIEP皮瓣重建的患者,按无新辅助治疗、单纯化疗、化疗联合放疗分组,比较内乳动脉与腹壁下深动脉的组织病理学改变及临床结局。各组动脉中膜厚度、管腔面积、动脉粥样硬化、钙化及弹性纤维断裂均无显著差异,皮瓣丢失率6%且组间可比,仅吻合时间组间差异有统计学意义。

要点

  • 新辅助化疗或化疗联合放疗未导致内乳动脉与腹壁下深动脉显著组织病理学恶化。
  • 即刻DIEP皮瓣重建在乳腺切除同期进行,显微外科上可行且临床安全。
  • 各组皮瓣丢失率无显著差异,吻合时间组间存在差异但临床意义需结合具体情况判断。

核心结论

  • 新辅助化疗和放疗似乎不会引起内乳动脉或腹壁下深动脉显著的组织病理学退化。
  • 新辅助治疗后于乳房切除同期行即刻DIEP皮瓣重建在显微外科上可行且临床安全。

研究设计与样本

  • 单中心回顾性队列研究,纳入2019至2023年83例女性乳腺癌患者,均行保留乳头乳晕乳房切除后即刻DIEP皮瓣重建。
  • 患者分为三组:无新辅助治疗组(组1)、单纯化疗组(组2)、化疗联合放疗组(组3)。
  • 对内乳动脉和腹壁下深动脉节段行组织学检查,评估中膜厚度、管腔面积、动脉粥样硬化、钙化及弹性纤维断裂。
  • 同时分析吻合时间和皮瓣丢失等临床参数,统计采用ANOVA、Kruskal-Wallis、卡方或Fisher精确检验。

主要发现

  • 各组中膜厚度无显著差异(内乳动脉p=0.230;腹壁下深动脉p=0.327)。
  • 各组管腔面积无显著差异(内乳动脉p=0.061;腹壁下深动脉p=0.134)。
  • 动脉粥样硬化评分和钙化在各组间无显著差异。
  • 内乳动脉弹性纤维断裂在各组间无显著差异(p=0.627)。
  • 83例中5例发生皮瓣丢失(6%),各组间可比(p=0.131);平均吻合时间组1、组2、组3分别为60.7±13.3、55.1±11.7、66.1±14.8(p=0.011)。

关键数值与推荐

  • 组织病理学评估指标包括中膜厚度、管腔面积、动脉粥样硬化、钙化及弹性纤维断裂。
  • 皮瓣丢失定义为临床结局指标,83例中发生5例(6%)。
  • 吻合时间以均值±标准差表示,组1为60.7±13.3,组2为55.1±11.7,组3为66.1±14.8,组间p=0.011。

临床怎么用

  • 对于接受新辅助化疗或化疗联合放疗的乳腺癌患者,可考虑在乳房切除同期行即刻DIEP皮瓣重建。
  • 术前无需仅因新辅助治疗史而额外担忧内乳动脉或腹壁下深动脉的组织病理学退化而放弃显微外科重建。
  • 吻合时间在化疗联合放疗组略长,术中可据此合理规划手术节奏。

局限性

  • 单中心回顾性设计,样本量83例,可能存在选择偏倚。
  • 未报告放疗与化疗的具体方案、剂量及与手术的时间间隔。
  • 组织病理学评估仅针对内乳动脉和腹壁下深动脉,未涵盖其他微血管。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of neoadjuvant chemotherapy (CT) and radiotherapy (RT) on the microvasculature critical for autologous breast reconstruction remains unclear. The internal mammary artery (IMA) and deep inferior epigastric artery (DIEA) are key conduits in deep inferior epigastric perforator (DIEP) free flap surgery. Prior studies suggest that radiation and chemotherapeutic agents may induce vascular injury; however, the clinical relevance of such alterations in flap viability is debated. We aimed to evaluate whether neoadjuvant CT or combined CT+RT induce histopathological changes in the IMA and DIEA that could affect microvascular anastomosis or DIEP flap outcomes. METHODS: This single-center retrospective cohort study included 83 female patients with breast cancer who underwent nipple-sparing mastectomy followed by immediate DIEP flap reconstruction between 2019 and 2023. Patients were divided into three groups: no neoadjuvant therapy (Group 1), CT only (Group 2), and CT+RT (Group 3). Arterial segments from IMA and DIEA were histologically examined for tunica media thickness, lumen area, atherosclerosis, calcification, and elastic fiber fragmentation. Clinical parameters including anastomosis time and flap loss were also analyzed. Statistical analyzes were performed using ANOVA, Kruskal-Wallis, chi-square, or Fishers's exact tests, as appropriate. RESULTS: No significant differences were observed among the groups in terms of tunica media thickness (IMA, p = 0.230; DIEA, p = 0.327), lumen area (IMA, p = 0.061; DIEA, p = 0.134), atherosclerosis scores, or calcification. Elastic fiber fragmentation in the IMA also did not differ significantly (p = 0.627). Flap loss occurred in 5 of 83 patients (6%) and was comparable across the groups (p = 0.131). Mean anastomosis times were 60.7 ± 13.3, 55.1 ± 11.7, and 66.1 ± 14.8 in groups 1, 2, and 3, respectively (p = 0.011). CONCLUSION: Neoadjuvant CT and RT do not appear to cause significant histopathological deterioration of the IMA or DIEA. Immediate DIEP flap reconstruction performed at the time of mastectomy after neoadjuvant therapy appears to be microsurgically feasible and clinically safe.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Güray Ş, Erdem İ, Arı N, et al. Immediate DIEP flap breast reconstruction following neoadjuvant therapy: Histopathological assessment of vascular integrity in internal mammary and deep inferior epigastric arteries. J Plast Reconstr Aesthet Surg. 2026. PMID: 42705175. doi:10.1016/j.bjps.2026.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。